AI주식인사이트AI Stock Insight
C

셀로맥스사이언스

471820KOSDAQ

53.0 / 100

Reference Date: 2026-10-23

Financial Score20.5 / 40
News Sentiment12.5 / 25
Momentum6.0 / 20
Disclosure14.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Slightly up 2.3% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Selomax Science, established in 2014, is a company specializing in the development and distribution of high-quality health functional foods using natural ingredients sourced through global partnerships. It distributes products through pharmacies and online platforms, with 6,881 affiliated pharmacies as of 2025, and is expanding into Asian markets. The company also develops a diverse range of general pharmaceuticals and cosmetics.

Number of Employees

52people

Average Salary

43.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
15.45Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR
0.98Industry Average 1.204.0Point

In line with industry avg

ROE
6.49Industry Average 8.002.5Point

Below industry avg

Debt Ratio
2.61Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20253.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲2.6% (1-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼48.5% (1-year basis)

ROE Trend
2.0 / 4

Avg ROE 8.4% (declining, 2yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 4,080Won52-week high 6,98052-week low 3,715
1-month return4.0Point

1m +2.26% (slight rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 2Neutral 0Negative 0
  • Positive현금ㆍ현물배당결정 (분기배당)2026-10-08
  • Positive중간(분기)배당락2026-09-28